Tag: licensing

  • Copper Nanofilm Can Replace Rare Earth in Digital Displays

    Research chemists at Duke University in Durham, North Carolina have developed a film made of copper nanowires that could replace expensive rare earths now used in digital displays. The discovery by Duke chemistry professor Ben Wiley and grad student Aaron Rathmell appears online in the journal Advanced Materials (paid subscription required). Wiley has also started…

  • University Spin-Off Begins Trial of Stem Cell ALS Treatment

    A technology developed at Tel Aviv University in Israel and licensed to a spin-off company invokes the potential of bone-marrow stem cells as treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. A clinical trial, now in Israel and later in the U.S., to test the discovery is recruiting participants. The technology…

  • Long Term Effects Found in Simple Family Planning Method

    Women who used a simple method for family planning were found to continue using the method for two years after the first year of adoption. The research team from Georgetown University Medical Center and Population Reference Bureau in Washington, D.C. published their findings online in the Journal of Family Planning & Reproductive Health Care (paid…

  • Superbug Therapy Based on University Research in Development

    MGB Biopharma, a biotechnology company in Glascow, U.K., is developing a new antibiotic treatment for resistant infections including MRSA and Clostridium Difficile (C. Diff.) bugs. The company licensed the discoveries from labs at University of Strathclyde, also in Scotland, that they are developing into oral and IV -administered drugs. C. Diff. is a bacterium that…

  • University Licenses Cancer Drug Screening Technology

    A technology developed at University of Colorado in Boulder to screen drug compounds for potential cancer treatments has been licensed by the university to a Boulder start-up company. Suvica Inc. will develop the patented drug discovery technology into a marketable product. The drug discovery processes licensed to Suvica use a genetically modified Drosophila fruit fly…

  • Sanofi Division, Max Planck to Partner on Retinal Research

    Max Planck Society in Germany and Fovea Pharmaceuticals in Paris have agreed to a research and licensing agreement on therapies for restoring vision to patients with diseases affecting the retina. Fovea is the ophthalmology division of the French drug company Sanofi-Aventis. Fovea’s team plans to work with the Max Planck Institute of Biophysics in Frankfurt…

  • Biotech Developing Anti-Cancer Drugs Gets $15M Investment

    Tensha Therapeutics in Cambridge, Massachusetts says it has received $15 million in early stage financing to advance treatments for cancer by regulating the transcription of disease-associated genes. The series A investment — the first round of funding after a company’s initial seed capital — is provided by HealthCare Ventures, life science venture capital firm, also…

  • Companies Need Better Mix of Business, Patent Strategies

    Science and engineering companies often develop innovations based on multiple discoveries, which calls for better integration of their patent and business strategies, according to study by three intellectual property analysts. The paper by Deepak Somaya at the University of Illinois in Champaign-Urbana college of business (pictured left), with David Teece of University of California at…

  • Manufacturing Process Devised for More Economical LEDs

    Materials scientists at University of Florida in Gainesville have developed a new manufacturing process for light-emitting diodes, or LEDs, used in flat-panel displays and solid-state lighting. The process is described in an article now appearing in the journal Nature Photonics (paid subscription required), and has been licensed to a company for commercialization. Two research teams…

  • Engineers Build Compact, Inexpensive Microscope

    Researchers at University of California at Los Angeles (UCLA) have built a compact, light-weight microscope that uses holograms instead of lenses. The device is described in a paper published today in the journal Biomedical Optics Express, and a company has been formed to take it to market. The team developing the microscope is led by…